Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global Spinosad market size was valued at USD 704.47 Million in 2022 and will reach USD 1088.42 Million in 2028, with a CAGR of 7.52% during 2022-2028.
Spinosad is produced directly from the fermentation of a strain of Saccharo-polyspora spinosa. Production strains of S. spinosa have been selected for increased titers of spinosyns A and D, however, no genetic engineering techniques have been used in this process and no genetically-modified organisms are used in the production process. After fermentation, the Spinosad and D mixture is extracted from the fermentation broth, precipitated and dried to create technical spinosad, which is then formulated into end-use products. Spinosad technical material is also produced under pharmaceutical manufacturing guidelines to be used as a flea control agent in companion animals.
Strength
Spinosad is a broad-spectrum biological pesticide with far more insecticidal. activity than organophosphorus, carbamate, cyclopentadiene and other pesticides.
Increase downstream demand.
Weakness
The market is highly monopolized and technically difficult;
Unbalanced regional development.
Opportunity
Countries such as China began to participate in R&D and production of products;
Technological cooperation on a global scale will reduce regional disparities to some extent.
Threat
Fluctuation price of raw materials.
Alternative products.
Product shortages lead to high prices.
Region Overview:
Asia Pacific had the highest growth rate of all regions.
Company Overview:
Dow AgroSciences is one of the major players operating in the Spinosad market, holding a share of 66.51% in 2020.
Dow AgroSciences
Dow AgroSciences LLC produces agricultural chemicals for pest control and plant nutrition. The Company offers a wide range of products such as insecticides, herbicides, fumigants, and other chemicals. Dow AgroSciences serves customers globally.
ELANCO
Elanco operates as a global animal health company. The Company specializes in providing food and companionship for animals and various other social causes. Elanco's products include beef, dairy, swine, poultry, veterinary services, and safety measures.
Segmentation Overview:
By type, 89%-93% segment accounted for the largest share of market in 2021.
Application Overview:
By application, the Agro segment occupied the biggest share from 2017 to 2022.
Vet
Spinosad has been developed by Elanco Animal Health for a number of significant animal health uses that involve either direct application to animals, application to animal production premises, or bait applications to control adult Musca domestica.
Agro
Spinosad has been applied to over 200 different crops. It has been used to control caterpillars in cotton,102 loopers in cabbage, leafminers in various crops, leafrollers on apples, thrips in citrus, etc.
The Spinosad market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Spinosad market covered in Chapter 4:
Dow AgroSciences
Baicao Biotech Co., Ltd
ZheJiang Hisun Pharmaceutical
Elanco
QiLu Pharmaceutical
In Chapter 12 and Chapter 14.1, on the basis of types, the Spinosad market from 2018 to 2028 is primarily split into:
>93%
89%-93%
<89%
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Spinosad market from 2018 to 2028 covers:
Vet
Agro
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Spinosad market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Spinosad market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Spinosad industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Spinosad industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Spinosad market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Spinosad market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Spinosad market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Spinosad market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
2022
Spinosad is produced directly from the fermentation of a strain of Saccharo-polyspora spinosa. Production strains of S. spinosa have been selected for increased titers of spinosyns A and D, however, no genetic engineering techniques have been used in this process and no genetically-modified organisms are used in the production process. After fermentation, the Spinosad and D mixture is extracted from the fermentation broth, precipitated and dried to create technical spinosad, which is then formulated into end-use products. Spinosad technical material is also produced under pharmaceutical manufacturing guidelines to be used as a flea control agent in companion animals.
Strength
Spinosad is a broad-spectrum biological pesticide with far more insecticidal. activity than organophosphorus, carbamate, cyclopentadiene and other pesticides.
Increase downstream demand.
Weakness
The market is highly monopolized and technically difficult;
Unbalanced regional development.
Opportunity
Countries such as China began to participate in R&D and production of products;
Technological cooperation on a global scale will reduce regional disparities to some extent.
Threat
Fluctuation price of raw materials.
Alternative products.
Product shortages lead to high prices.
Region Overview:
Asia Pacific had the highest growth rate of all regions.
Company Overview:
Dow AgroSciences is one of the major players operating in the Spinosad market, holding a share of 66.51% in 2020.
Dow AgroSciences
Dow AgroSciences LLC produces agricultural chemicals for pest control and plant nutrition. The Company offers a wide range of products such as insecticides, herbicides, fumigants, and other chemicals. Dow AgroSciences serves customers globally.
ELANCO
Elanco operates as a global animal health company. The Company specializes in providing food and companionship for animals and various other social causes. Elanco's products include beef, dairy, swine, poultry, veterinary services, and safety measures.
Segmentation Overview:
By type, 89%-93% segment accounted for the largest share of market in 2021.
Application Overview:
By application, the Agro segment occupied the biggest share from 2017 to 2022.
Vet
Spinosad has been developed by Elanco Animal Health for a number of significant animal health uses that involve either direct application to animals, application to animal production premises, or bait applications to control adult Musca domestica.
Agro
Spinosad has been applied to over 200 different crops. It has been used to control caterpillars in cotton,102 loopers in cabbage, leafminers in various crops, leafrollers on apples, thrips in citrus, etc.
The Spinosad market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Spinosad market covered in Chapter 4:
Dow AgroSciences
Baicao Biotech Co., Ltd
ZheJiang Hisun Pharmaceutical
Elanco
QiLu Pharmaceutical
In Chapter 12 and Chapter 14.1, on the basis of types, the Spinosad market from 2018 to 2028 is primarily split into:
>93%
89%-93%
<89%
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Spinosad market from 2018 to 2028 covers:
Vet
Agro
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Spinosad market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Spinosad market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Spinosad industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Spinosad industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Spinosad market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Spinosad market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Spinosad market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Spinosad market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
